David Hipkiss

David Hipkiss

Presidente presso AlveoGene Ltd.

54 anni
Health Technology
Process Industries
Finance

Profilo

David John Hipkiss was the founder of Prosonix Ltd.
which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2012.
He is currently the Chairman of AlveoGene Ltd.
since 2023.
Mr. Hipkiss's former jobs include being the Chief Executive Officer & Director of Enesi Pharma Ltd., a Principal at Air Products & Chemicals, Inc. and The Dow Chemical Co., the General Manager of Accentus LLC and Accentus Medical Ltd., a Principal at Chirotech Technology Ltd.
and Ascot Plc, and the Chief Business Officer of Niox Group Plc.
Mr. Hipkiss received an undergraduate degree from the University of Birmingham.

Posizioni attive di David Hipkiss

SocietàPosizioneInizio
Presidente 01/07/2023
Tutte le posizioni attive di David Hipkiss

Precedenti posizioni note di David Hipkiss

SocietàPosizioneFine
Corporate Officer/Principal -
Amministratore Delegato 01/07/2022
Ascot Plc Corporate Officer/Principal -
NIOX GROUP PLC Corporate Officer/Principal -
AIR PRODUCTS & CHEMICALS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di David Hipkiss

Formazione di David Hipkiss

University of Birmingham Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Hipkiss

Relazioni

4

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
AIR PRODUCTS & CHEMICALS, INC.

Process Industries

NIOX GROUP PLC

Health Services

Aziende private8

Health Technology

Technology Services

Process Industries

Finance

Ascot Plc

Distribution Services

Health Technology

Finance

Vedi le connessioni aziendali